1. Home
  2. PRME vs AIV Comparison

PRME vs AIV Comparison

Compare PRME & AIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$2.89

Market Cap

536.4M

Sector

Health Care

ML Signal

HOLD

Logo Apartment Investment and Management Company

AIV

Apartment Investment and Management Company

HOLD

Current Price

$2.91

Market Cap

435.9M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRME
AIV
Founded
2019
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
536.4M
435.9M
IPO Year
2022
1996

Fundamental Metrics

Financial Performance
Metric
PRME
AIV
Price
$2.89
$2.91
Analyst Decision
Buy
Buy
Analyst Count
6
1
Target Price
$7.56
$10.00
AVG Volume (30 Days)
2.8M
1.2M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
87.41%
EPS Growth
18.18
616.00
EPS
N/A
N/A
Revenue
$4,632,000.00
$138,486,000.00
Revenue This Year
$7.06
N/A
Revenue Next Year
$47.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
55.28
N/A
52 Week Low
$1.40
$2.89
52 Week High
$6.94
$8.87

Technical Indicators

Market Signals
Indicator
PRME
AIV
Relative Strength Index (RSI) 41.40 12.27
Support Level $2.68 N/A
Resistance Level $3.72 $4.30
Average True Range (ATR) 0.28 0.07
MACD -0.00 -0.16
Stochastic Oscillator 21.98 0.00

Price Performance

Historical Comparison
PRME
AIV

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

About AIV Apartment Investment and Management Company

Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment, and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development. Operating, and Other. The development segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. The operating segment includes residential apartments, communities with apartment homes that have achieved a stabilized level of operations. The other segment includes The Benson Hotel, the company's only hotel. The majority of revenue is gained from the Operating Segment.

Share on Social Networks: